Martin H. Huber Jr., President, CEO at Mersana Therapeutics, Inc. (MRSN), sold 100,846 shares at $1.76 ($177K) on 2024-09-12, disclosed to the SEC on 2024-09-13.
Scheduled sale ($177k) by President, CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.76 | 50,423 | $89K | 50.0% |
| 2 | $1.76 | 50,423 | $89K | 50.0% |
| Total | $1.76 avg | 100,846 | $177K | 100% |
| Filing → |
| MRSN | SELL | 2025-01-17 | $3K | — | Filing → |
| TSRO | SELL | 2018-09-25 | $14K | — | Filing → |
| TSRO | SELL | 2018-03-05 | $198K | — | Filing → |